Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives. [electronic resource]
- Cancer treatment reviews Dec 2013
- 908-24 p. digital
Publication Type: Journal Article; Review
1532-1967
10.1016/j.ctrv.2013.02.004 doi
Angiogenesis Inhibitors--therapeutic use Antibodies, Monoclonal--therapeutic use Biomarkers, Tumor--analysis Clinical Trials as Topic Colorectal Neoplasms--blood supply Humans Treatment Outcome